Life-saving treatments for children with orphan illnesses often move slowly, if at all, through the federal approval process.
The Hunter syndrome space suffered a setback in February when the FDA turned down REGENXBIO's investigational gene therapy, ...
Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But ...
WASHINGTON, DC, CA, UNITED STATES, February 24, 2025 /EINPresswire.com/ -- – Project Alive, a leading nonprofit dedicated to advancing research and support for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results